Hanna Wedad M., Kahn Harriette J., Chapman Judy-Anne W., Fish Edward B., Lickley H. Lavina A., McCready David R.
Women's College Hospital, University of Toronto, Toronto, Canada.
Breast J. 1999 Mar;5(2):105-111. doi: 10.1046/j.1524-4741.1999.00133.x.
Breast conservation surgery (BCS) plus irradiation has been shown to be equivalent to mastectomy in controlling ipsilateral breast cancer recurrence. The purpose of this study is to evaluate the factors that determine the rate of local recurrence in a group of patients treated with partial mastectomy without postoperative radiation, adjuvant hormonal therapy, or chemotherapy. We also assess the role of standard pathologic features, specifically lymphovascular invasion (LVI) in identifying high- and low-risk subsets of patients. We have a cohort of 293 patients treated with partial mastectomy followed prospectively for a median of 8 years. Data collected included patient's age, tumor size, tumor morphology, tumor grade, the extent of ductal carcinoma in situ (DCIS), the presence of LVI, lymph node status, and hormone receptors. Statistical analyses carried out were Kaplan-Meier plots with Wilcoxon (Peto-Prentice) test statistics for univariate analysis and Cox stepwise regression for multivariate analysis; the end point was local recurrence. The relapse rate in this cohort was 26%. In univariate analysis the significant factors associated with prolonged disease-free survival included older age, negative nodes, positive estrogen receptor (ER) status, and absence of LVI. Small tumor size was significant only in the univariate analysis. In the multivariate analysis, absence of comedocarcinoma entered the model in addition to the other variables. If the variables are stratified, a group of 66 patients with 6% local recurrence rate was identified. These were node-negative women >/=50 years of age with no LVI, no comedo DCIS, and ER-positive tumors. This study clearly indicates the important role of pathologic parameters in assessing the risk of recurrence.
保乳手术(BCS)加放疗已被证明在控制同侧乳腺癌复发方面与乳房切除术等效。本研究的目的是评估在一组接受部分乳房切除术且未进行术后放疗、辅助激素治疗或化疗的患者中,决定局部复发率的因素。我们还评估标准病理特征,特别是淋巴管浸润(LVI)在识别高危和低危患者亚组中的作用。我们有一组293例接受部分乳房切除术的患者,前瞻性随访中位时间为8年。收集的数据包括患者年龄、肿瘤大小、肿瘤形态、肿瘤分级、导管原位癌(DCIS)范围、LVI的存在、淋巴结状态和激素受体。进行的统计分析包括用于单变量分析的Kaplan-Meier图和Wilcoxon(Peto-Prentice)检验统计量,以及用于多变量分析的Cox逐步回归;终点是局部复发。该队列中的复发率为26%。在单变量分析中,与无病生存期延长相关的显著因素包括年龄较大、淋巴结阴性、雌激素受体(ER)状态阳性和无LVI。小肿瘤大小仅在单变量分析中有显著意义。在多变量分析中,除其他变量外,筛状癌的不存在进入了模型。如果对变量进行分层,可识别出一组66例局部复发率为6%的患者。这些是年龄≥50岁、无LVI、无筛状DCIS且ER阳性肿瘤的淋巴结阴性女性。本研究清楚地表明了病理参数在评估复发风险中的重要作用。